Women's Health Devices 2021 Medical Devices Pipeline Product Landscape Report - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Women's Health Devices - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information about the Women's Health Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Women's Health that focuses on the treatment and diagnosis of diseases and conditions that affect a woman's physical and emotional well-being.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Women's Health Devices under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Women's Health Devices and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

• The report enables you to -
• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Women's Health Devices under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

   

Key Topics Covered:

1 Table of Contents

2 Introduction

2.1 Women's Health Overview

3 Products under Development

3.1 Women's Health Devices - Pipeline Products by Stage of Development

3.2 Women's Health Devices - Pipeline Products by Territory

3.3 Women's Health Devices - Pipeline Products by Regulatory Path

3.4 Women's Health Devices - Pipeline Products by Estimated Approval Date

3.5 Women's Health Devices - Ongoing Clinical Trials

4 Women's Health Devices - Pipeline Products under Development by Companies

4.1 Women's Health Devices Companies - Pipeline Products by Stage of Development

4.2 Women's Health Devices - Pipeline Products by Stage of Development

5 Women's Health Companies and Product Overview

6 Women's Health- Recent Developments

7 Appendix

Companies Mentioned

• Advanced Tactile Imaging Inc
• Aethlon Medical Inc
• Agile Therapeutics Inc
• Amniotix Technologies Ltd
• ANALYTICA PTY LTD
• Aneeve Nanotechnologies LLC
• Astinno Ltd
• Bayer AG
• Baymatob Operations Pty Ltd
• Baystate Medical Center
• Becton Dickinson and Co
• BeFree!
• BioAesthetics Corp
• Biorings LLC
• Biostruxs LLC
• Birmont Medical Ltd.
• Bloomlife, Inc.
• Cambridge Consultants Ltd
• Cambridge Design Partner Ltd.
• Cath Med Ltd.
• CervoCheck, LLC
• Citius Pharmaceuticals LLC
• CommonSense Ltd.
• CX Therapeutics Inc
• Dare Bioscience Inc
• Dartmouth College
• Daye Ltd
• DermaDiagnostics
• Discreet Secrete Solutions
• DS Labs, Inc
• Earth Science Tech Inc
• Eli Science Inc
• Embryyo Technologies Pvt Ltd
• Emory University
• Enox Biopharma Inc (Inactive)
• Evestra Inc
• Evofem Biosciences Inc
• Fannin Partners LLC
• Femasys Inc
• Ferring Pharmaceuticals AS
• Fetal Life LLC
• Fibro Control (Israel) Ltd (Inactive)
• Fotona LLC
• FP Medtech Inc
• Gals Bio Ltd
• Global Health Partnerships
• Glyciome LLC
• Grunenthal Ltd
• Haemek Medical Center
• Healingstone Co Ltd
• Hera Health Solutions
• Herbio Co Ltd
• Hong Kong Polytechnic University
• IcosaMed Sarl
• Idoman Teoranta
• Igantia Therapeutics
• Imperial College London
• In Veritas Medical Diagnostics Inc (Inactive)
• Innometrix
• Invent Medic Sweden AB
• J3 Bioscience Inc
• Jibon Health Technologies, Inc.
• Johns Hopkins University
• Joylux Inc
• Keratin Biosciences Inc
• KynderMed Inc
• Laboratorios Andromaco
• Liv Labs Inc
• Madorra Inc
• Magee-Womens Research Institute
• Massachusetts Institute of Technology
• Materna Medical Inc.
• Maziwa
• McGill University Health Center
• Medela AG
• MEDITE Cancer Diagnostics Inc (Inactive)
• Medprin Regenerative Medical Technologies Co Ltd
• MenoPal
• Merck Serono SA
• MFB Fertility Inc
• Mithra Pharmaceuticals SA
• Momtec Life Ltd.
• Myant Inc
• Nagasaki University
• NaturalCycles Nordic AB
• NipaYe
• Nipro Corp
• Northwestern University
• Novela Inc
• Noventure SL
• OB Smart Ltd
• ObsteCare AB
• Obstetrx Inc
• OmniBiome Therapeutics Inc
• OncoGenesis
• Ondine Biomedical Inc
• Onko Solutions, LLC
• Orion Biotechnology Canada Ltd
• PEPTONIC medical AB
• Pink Luminous Breast
• Polumiros Inc
• PolyNovo Biomaterials Pty Ltd
• Positive Care Ltd
• PregnanTech Ltd
• Purdue University
• Qurasense Inc
• Rambam Health Care Campus
• Reia LLC
• Rejoni Inc
• Renovia Inc
• Resultados y Calidad del Sistema Sanitario Publico de Andalucia
• Rice University
• Stanford University
• Starpharma Holdings Ltd
• TCM Biosciences Inc
• Tecuro AG
• TeVido BioDevices LLC
• The Cooper Companies Inc
• The Feinstein Institute for Medical Research
• TruScreen Ltd
• University of Auckland
• University of California San Francisco
• University of Duisburg-Essen
• University of Erlangen-Nurnberg
• University of Florida
• University of Liverpool
• University of Maryland Baltimore
• University of Minnesota
• University of Pittsburgh
• University of Sheffield
• University of South Florida
• University of Technology of Compiegne
• University of Utah
• University of Waterloo
• VeriTeQ Corporation
• Virginia Commonwealth University
• VivoPlex Ltd
• Wave Intelligence Inc
• Zambon Italia Srl
• ZR-Operculum, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/t60gj6.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900